High density of benzodiazepine binding sites in the substantia innominata of the rat.
In order to study the neuronal basis of the pharmacological interactions between benzodiazepine receptor ligands and cortical cholinergic turnover, we examined the regional distribution of specific benzodiazepine binding sites using in vitro autoradiography. In the basal forebrain, the substantia innominata contained a high density of [3H]lormetazepam (LMZ) binding sites (Bmax = 277 fmol/mg tissue; Kd = 0.55 nM). The label could be displaced by diazepam (IC50 = 100 nM), the benzodiazepine receptor antagonist beta-carboline ZK 93426 (45 nM) and the partial inverse agonist beta-carboline FG 7142 (540 nM). It is hypothesized that the amnesic effects of benzodiazepine receptor agonists are exerted through benzodiazepine receptors which are situated on cholinergic neurons in the substantia innominata and are involved in a tonic inhibition of cortical acetylcholine release. The benzodiazepine receptor antagonist ZK 93426 may exert its nootropic effects via benzodiazepine receptors in the substantia innominata and, consequently, by disinhibiting cortical acetylcholine release.
Sarter
M
M
Research Laboratories of Schering AG, Berlin and Bergkamen, F.R.G.
Schneider
H H
HH
D000818:Animals; D014151:Anti-Anxiety Agents; D001345:Autoradiography; D001479:Basal Ganglia / Q000378:metabolism*; D001569:Benzodiazepines; D001921:Brain / Q000378:metabolism*; D007700:Kinetics; D008140:Lorazepam / Q000031:analogs & derivatives / Q000378:metabolism; D008297:Male; D009928:Organ Specificity; D051381:Rats; D011919:Rats, Inbred Strains; D011963:Receptors, GABA-A / Q000378:metabolism*; D013377:Substantia Innominata / Q000378:metabolism*; D014316:Tritium
D014151:Anti-Anxiety Agents; D011963:Receptors, GABA-A; D014316:Tritium; D001569:Benzodiazepines; C023842:lormetazepam; D008140:Lorazepam